1 Uzman Bulunan

Odak Alanları:

  • Tıbbi Onkoloji                      İç Hastalıkları                      Fitoterapi

Uygun Saatler:

  • monday 08:30 - 09:30
  • monday 17:00 - 19:00
  • tuesday 08:30 - 09:30
  • tuesday 17:00 - 19:00
  • wednesday 08:30 - 09:30
  • wednesday 17:00 - 19:00
  • thursday 09:00 - 17:00
  • friday 08:30 - 09:30
  • friday 17:00 - 19:00
  • saturday 09:00 - 12:00

Yayınlar

1. Uluslar Arası Hakemli Dergilerde Yayınlanan Makaleler
  1. Taş F., H. Karagöl, A. Karadeniz, E. Topuz, “Phlebitis due to Irinotecan”, Clin Oncol, 15 (3), 167 (2003).

  2. Şakar B., H. Karagöl, M. Gümüş, M. Başaran, E. Kaytan, A. Argon, Z. Ustuner, S. E. Bavbek, D. Bugra, F. N. Aykan, “Timing of death from tumor recurrence after curative gastrectomy for gastric cancer”, Am J Clin Oncol, 27 (2), 205-209 (2004).

  3. Şakar B., Z. Üstüner, H. Karagöl, G. Aksu, H. Çamlıca, F. N. Aykan, “Prognostic features and survival of ınoperable hepatocellular carcinoma in Turkish patients with cirrhosis”, Am J Clin Oncol, 27 (2), 489-493 (2004).

  4. Taş F, Z. Üstüner, G. Can, Y. Eralp, H. Çamlıca, M. Başaran, H. Karagöl, B. Şakar, R. Dişçi, E. Topuz, “The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients” Acta Oncol, 44 (2),161-167 (2005).

  5. Karagöl H., D. Derin, M. Başaran, S. Bavbek, “Isolated skeletal muscle recurrence of the paranasal sinus lymphoma in complete remission”, Med Oncol, 22, 313-317 (2005).

  6. Uygun K., H. Karagöl, Z. Koçak, İ. Çiçin, Ö. Yalçın, M. Çaloğlu, O. Şimsek, F. Akbay Harmandar, “Isolated bone metastasis in testicular germ cell tumors:a case report and review of the literature”, Onkologie, 29, 93-95 (2006)

  7. Çaloğlu M., V. Yürüt Çaloğlu, Ş. Altaner, G. Hüseyinova, E. Ünlü, H. Karagöl, C. Uzal, “Oncocytic carcinoma of the parotid gland”, Onkologie, 29, 388-390 (2006).

  8. Karagöl H., P. Saip, K. Uygun, S. Küçücük, A. Aydıner, E. Topuz, “Evaluation of prognostic factors and comperison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma”, Med Oncol, 23 (4), 543-548 (2006).

  9. Çiçin İ., H. Karagöl, S. Uzunoğlu, K. Uygun, “Efficient and safe application of a FOLFIRI/Bevacizumab combination to a patient with locally advanced rectal cancer and severe renal failure”, Onkologie, 30, 65 (2007).

  10. Turgut N., H. Karagöl, Y. Celik, K. Uygun, A. Reyhani, “Subacute motor neuronopathy associated with hepatocellular carcinoma”, J Neurooncol, 83 (1), 95-96 (2007).

  11. Karagöl H., P. Saip, K. Uygun, M. Çaloğlu, Y. Eralp, F. Taş, A. Aydıner, E. Topuz, “The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer”, Med Oncol, 24 (1), 39-43 (2007). 

  12. Coşar-Alas R, V. Yürüt-Çaloğlu, H. Karagöl, M. Çaloğlu, O. Yalçın, B. Turgut, M. Saynak, C. Uzal, “Paraneoplastic syndrome of non-small cell lung carcinoma: a case with pancytopenia, leukocytoclastic vasculitis, and hypertrophic osteoarthropathy’’, Lung Cancer, 56(3), 455-458 (2007). 

  13. Yürüt Çaloğlu V., M. Çaloğlu, F. Özyılmaz, M. Saynak, R. Coşar Alas, H. Karagöl, G. Bayır-Angın, C. Uzal, “Lung, bone, skeletal muscles and cutaneous metastases from adenoid cystic carcinoma of the parotid gland: a case report and review of the literature”, Med Oncol, 24(4), 458-462 (2007).

  14. Çaloğlu M., V. Yürüt Çaloğlu, R. Coşar Alas, M. Saynak, H. Karagöl, C. Uzal, “An ambiguos phenomenon of radiation and drugs: recall reactions”, Onkologie, 30(4), 209-214 (2007).

  15. Çiçin İ, H. Karagöl, S. Uzunoğlu, K. Uygun, U. Usta, Z. Koçak, M. Çaloğlu, M. Saynak, F. Tokatlı, C. Uzal, ‘‘ Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study’’, Cancer, 110 (5), 1068-1076 (2007). 

  16. Yurut-Caloglu V., M. Caloglu, F. Oz-Puyan, E. Unlu, H. Karagöl, K. Ibis, C. Uzal. “An unusual metastatic site of tongue carcinoma: Shoulder muscles” Auris Nasus Larynx, 35(3), 443-446 (2008).

  17. Saip P., I. Çiçin, Y. Eralp, S. Küçücük, S. Tuzlalı, H. Karagöl, I. Aslay, E. Topuz, ‘‘Factors affecting the prognosis of breast cancer patients with brain metastases’’, Breast, 17(5), 451-458 (2008).

  18. Uygun K., G. Aksu, İ. Çiçin, H. Karagöl, Z. Koçak, M. Fayda, A. Binici, F. Uzunoğlu, ‘‘The efficiency of single agent docetaxel in patients with platinum-refractory non-small cell lung carcinoma’’, Med Oncol, 25(4),408-414 (2008).

  19. Yurut-Caloglu V., M. Caloglu, FN Turan, K. Ibis, H. Karagol, Z. Kocak, C. Uzal, “The better performance status, the better outcome: laryngeal carcinoma treated with definitive radiotherapy”, J Otolaryngol Head Neck Surg, 37(6),799-806 (2008).

  20. Cicin I, H. Karagol, U. Usta, A. Sezer, S. Uzunoglu, R. Alas-Cosar, T. Yetisyigit, K. Uygun,Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer” Med Oncol, 26(3),335-43 (2009).

  21. Kaplan M., M. Çaloğlu, V. Yürüt Çaloğlu, T. Aktoz, U. Usta, H. Karagöl, O. İnce, “Parotid Gland Metastasis from Renal Cell Carcinoma: An Unusual Site for Metastatsis”, Am J Case Rep, 9, 316-320 (2008).

  22. Çiçin I., F. Özyilmaz, H. Karagöl, F. Yalçın, S. Uzunoğlu, M Kaplan, ‘‘ Massive Upper Gastrointestinal Bleeding From Pure Metastatic Choriocarcinoma in Patient with Mixed Germ Cell Tumor with Subclinical Intestinal Metastasis’’ Urology, 73(2),Art. No. 443-e15-17 (2009).

  23. Cicin I., U. Usta, H. Karagol, S. Uzunoglu, Z. Kocak, “Extrapulmonary small cell carcinoma localized in lymph nodes: Is it a different clinical entity”, Acta Oncologica, 48(3),354-360 (2009).

  24. Cicin I., U. Usta, A. Sezer, S. Canbaz, S. Uzunoglu, H. Karagol, H. Genchellac, AR. Karasalihoglu, “Synchronous Tonsil, Gallbladder, and Cardiac Metastases without any other Visceral Metastases of Malignant Melanoma” Onkologie, 32(4),197-199 (2009).

  25. Saip P., I. Cicin, Y. Eralp, H. Karagol, S. Kucucuk, RC. Alas, E. Yavuz, M. Dincer, E. Saglam, E. Topuz, “Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis”, J Neurooncol, 93(2), 243-251 (2009).

  26. Uygun K, A. Bilici, H. Karagol, M. Caloglu, I. Cicin, G. Aksu, M. Fayda, S. Uzunoglu, “The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck” Cancer Chemother Pharmacol, 64(3), 601-5 (2009).

  27. Özen, A., İ. Çiçin, A. Sezer, S. Uzunoğlu, M. Saynak, H. Gençhellaç, H. Karagöl, “Dural Sinus Vein Trombosis in a Patient with colon cancer treated with FOLFIRI/bevasizumab” , J Cancer Res Ther, 5(2), 130-132 (2009).

  28. Karagol,  H.,  P. Saip, Y. Eralp, S. Topuz, S. Berkman, R. Ilhan, E. Topuz, “Factors related to recurrence after pathological complete response to postoperative chemotherapy in patients with epithelial ovarian cancer” Tumori, 95(2), 207-211 (2009).

  29. Caloglu, M.,  V. Yurut-Caloglu, H. Karagol,  G. Bayir-Angin, FN.Turan,  C. Uzal, "Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience" J BUON,  14(2), 211-218 (2009).

  30. Yurut-Caloglu, V., M. Caloglu, M. Kaplan, F. Oz-Puyan, H. Karagol, K. Ibis, R. Cosar-Alas, Z. Kocak, O. Inci, "Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey" Eur J Cancer Care,  19(5), 656-663 (2010).

  31. Cosar-Alas, R., A. Alas, A. Ozen, B. Denizli, M. Saynak, S. Uzunoglu, N. Aydogdu, H. Karagol, C. Uzal, Z. Kocak, “Capecitabine-related intracranial hypotension syndrome mimicking dural metastasis in a breast cancer patient: case report and review of the literature”, J Cancer Res Ther, 6(4), 557-559 (2010).

  32. Uzunoglu, S., H. Karagol, F. Ozpuyan, R. Cosar, İ. Cicin, V. Yurutcaloglu, B. Denizli, Ö. Tanriverdi, N. Sut, Z. Kocak, "Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats", Med Oncol, Suppl 1: S690-699 (2011).

  33. Kocak, Z., M. Saynak, K. Uygun, Y. Yoruk, A. Ozen, N. Sut, G. Altiay, M. Caloglu, A. Karamustafaoglu, U. Usta, H. Karagol, ON Hatipoglu, ” Trimodality treatment in patients with superior sulcus tumors: hopes and realities”, Tumori, 97(4), 459-465 (2011).

  34. Ozen A,  Z. Kocak, T. Sipahi, F. Oz-Puyan, S. Cakina, M. Saynak, C. Ibis, H. Karagol. “The prognostic significance of p21 and Her-2 gene expression and mutation/polymorphism in patients with gastric adenocarcinoma” Med Oncol, 30(1), 357 (2013).